Google
ETON — ETON PHARMACEUTICALS INC (Healthcare >> Drug Manufacturers - Specialty & Generic)
ETON FAQ
What is ETON's P/E ratio?
ETON PHARMACEUTICALS INC (ETON) currently trades at a P/E ratio of 279.15.
What is ETON's ROE?
ETON PHARMACEUTICALS INC reports a Return on Equity (ROE) of -4.82%.
What is ETON's dividend yield?
ETON PHARMACEUTICALS INC offers a dividend yield of 0.00%.
What is ETON's Deepscope Quality Score?
Deepscope rates ETON's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy ETON?
Deepscope's AI Timing Score for ETON is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does ETON belong to?
ETON PHARMACEUTICALS INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 32.11
Price
1.16
(3.75%)
Day Change
|
|
|---|
ETON, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 32.11 |
| PBV / Sector |
27.69 / 2.57
|
| Earning Per Share | -0.06 |
| PE / Sector |
279.15 / 24.33
|
| PEG or PE/Growth / Sector |
3.63 / 0.12
|
| Average 1M Daily Value |
12.41 M
GREAT
|
| Average 1W Daily Value |
8.99 M
|
| Timing Factors |
|
71% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
60% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-06-12 09:43:15 |
| Symbol | ETON |
| Name | ETON PHARMACEUTICALS INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 27.39 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 847.79 / 9,929.32 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 21925 W. Field Parkway, Deer Park, IL, United States, 60010-7278
Phone: 847 787 7361
Website: https://www.etonpharma.com
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
